ASX - By Stock
|
SER |
Re:
Ann: Change in substantial holding
|
|
Whampoa
|
32 |
8.6K |
1 |
12/06/24 |
12/06/24 |
ASX - By Stock
|
32
|
8.6K
|
1
|
|
ASX - By Stock
|
COV |
Re:
Ann: COV Ovarian Cancer Blood Test Outperforms Clinical Benchmark
|
|
Whampoa
|
50 |
11K |
3 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
50
|
11K
|
3
|
|
ASX - By Stock
|
SER |
Re:
SER Chart
|
|
Whampoa
|
120 |
33K |
0 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
120
|
33K
|
0
|
|
ASX - By Stock
|
SER |
Re:
SER Chart
|
|
Whampoa
|
120 |
33K |
1 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
120
|
33K
|
1
|
|
ASX - By Stock
|
VTX |
Re:
Ann: Term Sheet for US$10M Prepayment Facility
|
|
Whampoa
|
34 |
6.3K |
2 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
34
|
6.3K
|
2
|
|
ASX - By Stock
|
VTX |
Re:
Ann: Term Sheet for US$10M Prepayment Facility
|
|
Whampoa
|
34 |
6.3K |
2 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
34
|
6.3K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Positive final DEP irinotecan Phase 2 clinical trial results
|
|
Whampoa
|
42 |
10K |
3 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
42
|
10K
|
3
|
|
ASX - By Stock
|
AGC |
Re:
AGC Neighbours
|
|
Whampoa
|
21 |
9.1K |
3 |
25/05/24 |
25/05/24 |
ASX - By Stock
|
21
|
9.1K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Starpharma Business Update
|
|
Whampoa
|
17 |
5.1K |
2 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
17
|
5.1K
|
2
|
|
ASX - By Stock
|
AGC |
Re:
AGC Neighbours
|
|
Whampoa
|
21 |
9.1K |
2 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
21
|
9.1K
|
2
|
|
ASX - By Stock
|
AGC |
Re:
AGC Neighbours
|
|
Whampoa
|
21 |
9.1K |
7 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
21
|
9.1K
|
7
|
|
ASX - By Stock
|
AGC |
Re:
Ann: Achilles Delivers Outstanding Gold and Silver Results
|
|
Whampoa
|
205 |
86K |
9 |
18/05/24 |
18/05/24 |
ASX - By Stock
|
205
|
86K
|
9
|
|
ASX - By Stock
|
AGC |
Re:
Ann: Achilles Delivers Outstanding Gold and Silver Results
|
|
Whampoa
|
205 |
86K |
15 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
205
|
86K
|
15
|
|
ASX - By Stock
|
MAG |
Re:
Ann: Fortescue to farm-in on Myall & make cornerstone investment
|
|
Whampoa
|
112 |
44K |
7 |
11/05/24 |
11/05/24 |
ASX - By Stock
|
112
|
44K
|
7
|
|
ASX - By Stock
|
MAG |
Re:
Ann: Fortescue to farm-in on Myall & make cornerstone investment
|
|
Whampoa
|
112 |
44K |
3 |
20/04/24 |
20/04/24 |
ASX - By Stock
|
112
|
44K
|
3
|
|
ASX - By Stock
|
MAG |
Re:
Ann: Fortescue to farm-in on Myall & make cornerstone investment
|
|
Whampoa
|
112 |
44K |
23 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
112
|
44K
|
23
|
|
ASX - By Stock
|
SPL |
Re:
Ann: S&P DJI Announces March 2024 Quarterly Rebalance
|
|
Whampoa
|
27 |
6.4K |
5 |
02/03/24 |
02/03/24 |
ASX - By Stock
|
27
|
6.4K
|
5
|
|
ASX - By Stock
|
ACF |
Re:
Ann: Acrow reports another period of Record Financial Results
|
|
Whampoa
|
9 |
4.3K |
1 |
20/02/24 |
20/02/24 |
ASX - By Stock
|
9
|
4.3K
|
1
|
|
ASX - By Stock
|
RCL |
Re:
Ann: September 2023 Quarterly Report and Appendix 4C
|
|
Whampoa
|
12 |
4.5K |
0 |
18/02/24 |
18/02/24 |
ASX - By Stock
|
12
|
4.5K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Covid-19 is not over by a long shot ladies and gentlemen
|
|
Whampoa
|
102 |
22K |
1 |
10/02/24 |
10/02/24 |
ASX - By Stock
|
102
|
22K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Covid-19 is not over by a long shot ladies and gentlemen
|
|
Whampoa
|
102 |
22K |
1 |
10/02/24 |
10/02/24 |
ASX - By Stock
|
102
|
22K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Covid-19 is not over by a long shot ladies and gentlemen
|
|
Whampoa
|
102 |
22K |
1 |
10/02/24 |
10/02/24 |
ASX - By Stock
|
102
|
22K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Covid-19 is not over by a long shot ladies and gentlemen
|
|
Whampoa
|
102 |
22K |
0 |
10/02/24 |
10/02/24 |
ASX - By Stock
|
102
|
22K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Covid-19 is not over by a long shot ladies and gentlemen
|
|
Whampoa
|
102 |
22K |
0 |
09/02/24 |
09/02/24 |
ASX - By Stock
|
102
|
22K
|
0
|
|
ASX - By Stock
|
CYP |
Re:
Stem Cell News
|
|
Whampoa
|
515 |
122K |
9 |
08/02/24 |
08/02/24 |
ASX - By Stock
|
515
|
122K
|
9
|
|
ASX - By Stock
|
CYC |
Re:
Ann: Cyclopharm Trading and USA Launch Update
|
|
Whampoa
|
31 |
9.2K |
3 |
05/02/24 |
05/02/24 |
ASX - By Stock
|
31
|
9.2K
|
3
|
|
ASX - By Stock
|
MAG |
Re:
Ann: Quarterly Cashflow Report (Appendix 5B) - December 2023
|
|
Whampoa
|
23 |
5.6K |
1 |
05/02/24 |
05/02/24 |
ASX - By Stock
|
23
|
5.6K
|
1
|
|
ASX - By Stock
|
MAG |
Re:
Ann: Quarterly Cashflow Report (Appendix 5B) - December 2023
|
|
Whampoa
|
23 |
5.6K |
6 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
23
|
5.6K
|
6
|
|
ASX - By Stock
|
BSX |
Re:
Ann: Blackstone Signs Offtake MOU for Refinery Byproduct
|
|
Whampoa
|
28 |
6.9K |
0 |
23/01/24 |
23/01/24 |
ASX - By Stock
|
28
|
6.9K
|
0
|
|
ASX - By Stock
|
ACF |
Re:
Ann: Pause in Trading
|
|
Whampoa
|
19 |
6.2K |
0 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
19
|
6.2K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Whampoa
|
32 |
7.6K |
1 |
02/11/23 |
02/11/23 |
ASX - By Stock
|
32
|
7.6K
|
1
|
|
ASX - By Stock
|
CYC |
Re:
Ann: FDA Technegas Approval Webinar
|
|
Whampoa
|
64 |
17K |
4 |
20/10/23 |
20/10/23 |
ASX - By Stock
|
64
|
17K
|
4
|
|
ASX - By Stock
|
CYC |
Re:
Ann: FDA Technegas Approval Webinar
|
|
Whampoa
|
64 |
17K |
4 |
19/10/23 |
19/10/23 |
ASX - By Stock
|
64
|
17K
|
4
|
|
ASX - By Stock
|
CYC |
Re:
Ann: FDA Technegas Approval Webinar
|
|
Whampoa
|
64 |
17K |
0 |
05/10/23 |
05/10/23 |
ASX - By Stock
|
64
|
17K
|
0
|
|
ASX - By Stock
|
CYC |
Re:
Ann: SNMMI Announcement Regarding USFDA Approval of Technegas
|
|
Whampoa
|
19 |
4.8K |
3 |
04/10/23 |
04/10/23 |
ASX - By Stock
|
19
|
4.8K
|
3
|
|
ASX - By Stock
|
CYC |
Re:
Countdown
|
|
Whampoa
|
65 |
18K |
0 |
29/09/23 |
29/09/23 |
ASX - By Stock
|
65
|
18K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Deaths from Covid 19 continue to take toll
|
|
Whampoa
|
27 |
7.0K |
1 |
01/09/23 |
01/09/23 |
ASX - By Stock
|
27
|
7.0K
|
1
|
|
ASX - By Stock
|
CYC |
Re:
Countdown
|
|
Whampoa
|
65 |
18K |
6 |
29/08/23 |
29/08/23 |
ASX - By Stock
|
65
|
18K
|
6
|
|
ASX - By Stock
|
TER |
Re:
Ann: Quarterly Report - April to June 2023
|
|
Whampoa
|
68 |
25K |
0 |
27/08/23 |
27/08/23 |
ASX - By Stock
|
68
|
25K
|
0
|
|
ASX - By Stock
|
RIC |
Re:
Ann: FY23 Full Year Results Investor Presentation
|
|
Whampoa
|
9 |
3.3K |
0 |
19/08/23 |
19/08/23 |
ASX - By Stock
|
9
|
3.3K
|
0
|
|
ASX - By Stock
|
ACW |
Re:
Ann: ACW secures shortfall commitments of $4.56m for rights issue
|
|
Whampoa
|
18 |
6.3K |
1 |
15/08/23 |
15/08/23 |
ASX - By Stock
|
18
|
6.3K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Where is the bottom??
|
|
Whampoa
|
148 |
47K |
2 |
11/08/23 |
11/08/23 |
ASX - By Stock
|
148
|
47K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Mirrabooka creeps up the list of top 20 holders in Starpharma
|
|
Whampoa
|
43 |
13K |
0 |
05/06/23 |
05/06/23 |
ASX - By Stock
|
43
|
13K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Covid is not going away.
|
|
Whampoa
|
19 |
4.5K |
0 |
22/05/23 |
22/05/23 |
ASX - By Stock
|
19
|
4.5K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Covid is not going away.
|
|
Whampoa
|
19 |
4.5K |
0 |
22/05/23 |
22/05/23 |
ASX - By Stock
|
19
|
4.5K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Covid is not going away.
|
|
Whampoa
|
19 |
4.5K |
1 |
22/05/23 |
22/05/23 |
ASX - By Stock
|
19
|
4.5K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Covid is not going away.
|
|
Whampoa
|
19 |
4.5K |
1 |
22/05/23 |
22/05/23 |
ASX - By Stock
|
19
|
4.5K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Covid is not going away.
|
|
Whampoa
|
19 |
4.5K |
2 |
22/05/23 |
22/05/23 |
ASX - By Stock
|
19
|
4.5K
|
2
|
|
ASX - By Stock
|
ARF |
Re:
Ann: HY2023 Results Presentation
|
|
Whampoa
|
7 |
3.5K |
0 |
11/04/23 |
11/04/23 |
ASX - By Stock
|
7
|
3.5K
|
0
|
|
ASX - By Stock
|
ARF |
Re:
Ann: HY2023 Results Presentation
|
|
Whampoa
|
7 |
3.5K |
0 |
10/04/23 |
10/04/23 |
ASX - By Stock
|
7
|
3.5K
|
0
|
|